BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36722215)

  • 1. EMX2OS targeting IGF2BP1 represses Wilms' tumour stemness,epithelial-mesenchymal transition and metastasis.
    Zhang HM; Cui MY; Chen ZH
    J Genet; 2023; 102():. PubMed ID: 36722215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
    Chen ZH; Cui MY; Zhang HM
    Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the cGMP-PKG Signaling Pathway.
    Wang Z; Zhang C; Chang J; Tian X; Zhu C; Xu W
    Onco Targets Ther; 2020; 13():7045-7056. PubMed ID: 32801740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
    Shen J; Shu Q
    Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms' tumor by regulating the miR-514a-3p/MELK axis.
    Du J; Xiao J; Zhuo Y; Nie M; Yang J; Luo X; Gu H
    Anticancer Drugs; 2022 Sep; 33(8):720-730. PubMed ID: 35946509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
    Gu Y; Feng C; Liu T; Zhang B; Yang L
    PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.
    Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z
    J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-9 secreted by M2-type macrophages promotes Wilms' tumour metastasis through the PI3K/AKT pathway.
    Tian K; Du G; Wang X; Wu X; Li L; Liu W; Wu R
    Mol Biol Rep; 2022 May; 49(5):3469-3480. PubMed ID: 35107742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00667 promotes Wilms' tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β.
    Liu P; Chen S; Huang Y; Xu S; Song H; Zhang W; Sun N
    Cell Biol Int; 2020 Jun; 44(6):1382-1393. PubMed ID: 32129525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-572 targets CDH1 to promote metastasis of Wilms' tumor.
    Zhang C; Lv GQ; Cui LF; Guo CC; Liu QE
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3709-3717. PubMed ID: 31114995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG).
    Zirkel A; Lederer M; Stöhr N; Pazaitis N; Hüttelmaier S
    Nucleic Acids Res; 2013 Jul; 41(13):6618-36. PubMed ID: 23677615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 16. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
    Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
    Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA EMX2OS Induces Proliferation, Invasion and Sphere Formation of Ovarian Cancer Cells via Regulating the miR-654-3p/AKT3/PD-L1 Axis.
    Duan M; Fang M; Wang C; Wang H; Li M
    Cancer Manag Res; 2020; 12():2141-2154. PubMed ID: 32273754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.